{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:07:40Z","timestamp":1775596060284,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.pbb.2004.01.014","type":"journal-article","created":{"date-parts":[[2004,3,9]],"date-time":"2004-03-09T08:52:41Z","timestamp":1078822361000},"page":"775-781","source":"Crossref","is-referenced-by-count":16,"title":["Structure\u2013activity comparison of YZ-069, a novel \u03c3 ligand, and four analogs in receptor binding and behavioral studies"],"prefix":"10.1016","volume":"77","author":[{"given":"Rae R","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence Hourcade","family":"Potelleret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buddy","family":"Pouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne D","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2004.01.014_BIB1","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/jm00034a021","article-title":"Secondary amine analogues of 3\u03b2-(4\u2032-substituted phenyl) tropane-2\u03b2-carboxylic acid esters and N-norcocaine exhibit enhanced affinity for serotonin and norepinephrine transporters","volume":"37","author":"Boja","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2004.01.014_BIB2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0306-4522(96)00221-7","article-title":"[3H]1,3-Di(2-tolyl)guanidine and [3H](+)-pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes","volume":"6","author":"Bouchard","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2004.01.014_BIB3","first-page":"117","article-title":"[3H](+)-Pentazocine: a potent and highly selective benzomorphan-based probe for sigma-1 receptors","volume":"3","author":"Bowen","year":"1993","journal-title":"Mol. Neuropharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0028-3908(99)00151-3","article-title":"Prevention of cocaine-induced convulsions and lethality in mice: effectiveness of targeting different sites on the NMDA receptor complex","volume":"39","author":"Brackett","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2004.01.014_BIB5","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1021\/jm00101a011","article-title":"Synthesis and biological evaluation of conformationally restricted 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-ethylenediamines as \u03c3 receptor ligands: I. Pyrrolidine, piperidine, homopiperidine, and tetrahydroisoquinoline classes","volume":"35","author":"de Costa","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2004.01.014_BIB6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/jm00079a004","article-title":"Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl-N-alkyl-2-(1-pyrrolidinyl)ethylamines): structural requirements and binding affinity at the \u03c3 receptor","volume":"35","author":"de Costa","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2004.01.014_BIB7","doi-asserted-by":"crossref","first-page":"072","DOI":"10.1073\/pnas.93.15.8072","article-title":"Purification, molecular cloning, and expression of the mammalian sigma1-binding site","volume":"93","author":"Hanner","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pbb.2004.01.014_BIB8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0006-8993(90)91143-5","article-title":"A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain","volume":"527","author":"Hellewell","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2004.01.014_BIB9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0922-4106(94)90115-5","article-title":"Rat liver and kidney contain high densities of \u03c31 and \u03c32 receptors: characterization by ligand binding and photoaffinity labeling","volume":"268","author":"Hellewell","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB10","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1073\/pnas.85.8.2844","article-title":"Identification of the binding subunit of the sigma-type opiate receptor by photoaffinity labeling with 1-(4-azido-2-methyl[6-3H]phenyl)-3-(2-methyl[4,5-3H]phenyl)guanidine","volume":"85","author":"Kavanaugh","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pbb.2004.01.014_BIB12","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(01)00891-3","article-title":"(\u00b1)-SM 21 attenuates the convulsive and locomotor stimulatory effects of cocaine in mice","volume":"417","author":"Matsumoto","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(95)00208-3","article-title":"Characterization of two novel \u03c3 receptor ligands: antidystonic effects in rats suggest \u03c3 receptor antagonism","volume":"280","author":"Matsumoto","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0028-3908(01)00116-2","article-title":"Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters","volume":"41","author":"Matsumoto","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2004.01.014_BIB14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(01)00968-2","article-title":"Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting \u03c31 receptors produce anti-cocaine effects in mice","volume":"419","author":"Matsumoto","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(00)00917-1","article-title":"N-alkyl substituted analogs of the \u03c3 receptor ligand BD1008 and traditional \u03c3 receptor ligands affect cocaine-induced convulsions and lethality in mice","volume":"411","author":"Matsumoto","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0028-3908(02)00056-4","article-title":"Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides","volume":"42","author":"Matsumoto","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2004.01.014_BIB17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(03)01723-0","article-title":"\u03c3 Receptors: potential medications development target for anti-cocaine agents","volume":"469","author":"Matsumoto","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0149-7634(02)00017-9","article-title":"Sigma1 (\u03c31) receptor antagonists represent a new strategy against cocaine addiction and toxicity","volume":"26","author":"Maurice","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2004.01.014_BIB19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-2999(99)00113-2","article-title":"Two novel \u03c3 receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity","volume":"370","author":"McCracken","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(98)00876-0","article-title":"Novel \u03c3 receptor ligands attenuate the locomotor stimulatory effects of cocaine","volume":"365","author":"McCracken","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-2952(01)00666-9","article-title":"Molecular cloning and pharmacological characterization of the rat sigma1 receptor","volume":"62","author":"Mei","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(91)90355-T","article-title":"Selective \u03c3 ligands block stimulant effects of cocaine","volume":"201","author":"Menkel","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB23","first-page":"966","article-title":"Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies","volume":"44","author":"Moebius","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB24","first-page":"139","article-title":"Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action","volume":"43","author":"Moebius","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB25","doi-asserted-by":"crossref","first-page":"16871","DOI":"10.1021\/bi961996m","article-title":"Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors","volume":"35","author":"Moebius","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbb.2004.01.014_BIB26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-2999(95)00424-J","article-title":"Ionotropic action of sigma receptor ligands in isolated cardiac myocytes from adult rats","volume":"286","author":"Novakova","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1037\/1064-1297.8.1.133","article-title":"Antidepressant drugs appear to enhance cocaine-induced toxicity","volume":"8","author":"O'Dell","year":"2000","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB28","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1046\/j.1471-4159.1998.70062279.x","article-title":"Cloning and characterization of a mouse sigma1 receptor","volume":"70","author":"Pan","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.01.014_BIB29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130050197","article-title":"Cocaine-induced convulsions: pharmacological antagonism at serotonergic, muscarinic and sigma receptors","volume":"129","author":"Ritz","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.01.014_BIB30","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1097\/00001756-200009110-00011","article-title":"Involvement of the \u03c31 receptor in the cocaine-induced conditioned place preference","volume":"11","author":"Romieu","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.pbb.2004.01.014_BIB31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/bbrc.1997.7840","article-title":"Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor","volume":"241","author":"Seth","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pbb.2004.01.014_BIB32","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1046\/j.1471-4159.1998.70030922.x","article-title":"Cloning and functional characterization of a \u03c3 receptor from rat brain","volume":"70","author":"Seth","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.01.014_BIB33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0014-2999(88)90058-1","article-title":"Cocaine binding at \u03c3 receptors","volume":"149","author":"Sharkey","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB34","first-page":"477","article-title":"Effect of sigma ligands on the cocaine-induced convulsions in mice","volume":"51","author":"Skuza","year":"1999","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.01.014_BIB35","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1520\/JFS11042J","article-title":"Brain concentrations of cocaine and benzoylecgonine in fatal cases","volume":"30","author":"Spiehler","year":"1985","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.pbb.2004.01.014_BIB36","doi-asserted-by":"crossref","first-page":"18387","DOI":"10.1074\/jbc.274.26.18387","article-title":"Sigma receptor photolabeling and sigma receptor-mediated modulation of potassium channels in tumor cells","volume":"274","author":"Wilke","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbb.2004.01.014_BIB37","first-page":"473","article-title":"Effects of the selective sigma receptor ligand 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methyflavone (NPC 16377) on behavioral toxic effects of cocaine","volume":"266","author":"Witkin","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2004.01.014_BIB38","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1021\/jm9600813","article-title":"Synthesis and evaluation of aryl-substituted N-(arylethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamines and corresponding arylacetamides for \u03c3 receptor activity","volume":"39","author":"Zhang","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2004.01.014_BIB39","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1021\/jm980143k","article-title":"Characterization of novel N,N-disubstituted piperazines as \u03c3 receptor ligands","volume":"41","author":"Zhang","year":"1998","journal-title":"J. Med. Chem."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305704000322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305704000322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T13:54:23Z","timestamp":1550152463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305704000322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0091305704000322"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2004.01.014","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}